Pottage John C Jr - Net Worth and Insider Trading
Pottage John C Jr Net Worth
The estimated net worth of Pottage John C Jr is at least $84,500 dollars as of 2024-09-20. Pottage John C Jr is the SVP and Chief Medical Officer of Achillion Pharmaceuticals Inc and owns about 12,500 shares of Achillion Pharmaceuticals Inc (ACHN) stock worth over $84,500. Details can be seen in Pottage John C Jr's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Pottage John C Jr has not made any transactions after 2006-10-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Pottage John C Jr
Pottage John C Jr Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Pottage John C Jr owns 3 companies in total, including Spero Therapeutics Inc (SPRO) , Achillion Pharmaceuticals Inc (ACHN) , and Pardes Biosciences Inc (PRDS) .
Click here to see the complete history of Pottage John C Jr’s form 4 insider trades.
Insider Ownership Summary of Pottage John C Jr
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SPRO | Spero Therapeutics Inc | 2018-09-21 | director |
| ACHN | Achillion Pharmaceuticals Inc | 2006-12-19 | SVP and Chief Medical Officer |
| PRDS | Pardes Biosciences Inc | 2022-09-14 | director |
Pottage John C Jr Latest Holdings Summary
Pottage John C Jr currently owns a total of 1 stock. Pottage John C Jr owns 12,500 shares of Achillion Pharmaceuticals Inc (ACHN) as of October 25, 2006, with a value of $84,500.
Latest Holdings of Pottage John C Jr
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACHN | Achillion Pharmaceuticals Inc | 2006-10-25 | 12,500 | 6.76 | 84,500 |
Holding Weightings of Pottage John C Jr
Pottage John C Jr Form 4 Trading Tracker
According to the SEC Form 4 filings, Pottage John C Jr has made a total of 0 transactions in Achillion Pharmaceuticals Inc (ACHN) over the past 5 years. The most-recent trade in Achillion Pharmaceuticals Inc is the sale of 0 shares on October 25, 2006, which brought Pottage John C Jr around $0.
Insider Trading History of Pottage John C Jr
- 1
Pottage John C Jr Trading Performance
Pottage John C Jr Ownership Network
Pottage John C Jr Owned Company Details
What does Spero Therapeutics Inc do?
Who are the key executives at Spero Therapeutics Inc?
Pottage John C Jr is the director of Spero Therapeutics Inc. Other key executives at Spero Therapeutics Inc include Chief Development Officer Timothy Keutzer , director & See Remarks Ankit Mahadevia , and Chief Financial Officer Sath Shukla .
Spero Therapeutics Inc (SPRO) Insider Trades Summary
Over the past 18 months, Pottage John C Jr made no insider transaction in Spero Therapeutics Inc (SPRO). Other recent insider transactions involving Spero Therapeutics Inc (SPRO) include a net sale of 117,209 shares made by Sath Shukla , a net sale of 78,747 shares made by Ankit Mahadevia , and a net sale of 35,038 shares made by Timothy Keutzer .
In summary, during the past 3 months, insiders sold 43,323 shares of Spero Therapeutics Inc (SPRO) in total and bought 0 shares, with a net sale of 43,323 shares. During the past 18 months, 331,325 shares of Spero Therapeutics Inc (SPRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 331,325 shares.
Spero Therapeutics Inc (SPRO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Spero Therapeutics Inc Insider Transactions
Pottage John C Jr Mailing Address
Above is the net worth, insider trading, and ownership report for Pottage John C Jr. You might contact Pottage John C Jr via mailing address: Achillion Pharmaceuticals, 300 George Street, New Haven Ct 06511.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
